These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1693576)

  • 1. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
    Charton M; Timbal Y
    Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on enoxacin concentration in human prostatic tissue].
    Kitamura Y; Kataumi Z; Nakamura T; Takeda H
    Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
    Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S
    Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study.
    Desai KM; Abrams PH; White LO
    J Urol; 1988 Jun; 139(6):1232-4. PubMed ID: 2453683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin distribution in human tissues after multiple oral administration.
    Malmborg AS; Rannikko S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed-phase high-performance liquid chromatographic determination of enoxacin and 4-oxo-enoxacin in human plasma and prostatic tissue. Application to a pharmacokinetic study.
    Hamel B; Audran M; Costa P; Bressolle F
    J Chromatogr A; 1998 Jul; 812(1-2):369-79. PubMed ID: 9691332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.
    Patel SS; Spencer CM
    Drugs; 1996 Jan; 51(1):137-60. PubMed ID: 8741236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of norfloxacin in prostatic tissues following oral administration in patients with benign prostatic hyperplasia.
    Netto NR; Palma PC; Srulzon GB; Cortado PL; Fonseca RC
    Int Urol Nephrol; 1988; 20(1):47-9. PubMed ID: 2452139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxacin concentration in human prostatic tissue after oral administration.
    Rannikko S; Malmborg AS
    J Antimicrob Chemother; 1986 Jan; 17(1):123. PubMed ID: 2419299
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxacin penetration into human prostatic tissue.
    Bergeron MG; Roy R; Lessard C; Foucault P
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1433-4. PubMed ID: 3196004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.